Topic
AI
From foundation models to production deployment, our AI events convene the leaders scaling AI safely across regulated industries and critical infrastructure.
- Enterprise AI deployment at scale
- AI governance, safety and assurance
- Talent, capability and operating models
About AI at Global Engage
AI in life sciences has moved past the pilot phase. Foundation models are being fine-tuned on proprietary R&D data, generative chemistry is compressing hit-to-lead timelines, and clinical operations teams are automating protocol design, site selection and safety monitoring. The bottleneck is no longer the model, it's the operating model around it.
Global Engage's AI programme is built for the leaders responsible for making this real: heads of computational biology, digital and data officers in pharma and biotech, translational informatics leads, and the regulators shaping how AI-enabled evidence is accepted. Sessions pair peer-reviewed case studies from Roche, GSK, AstraZeneca and Novartis with candid discussion of what didn't work.
Expect deep-dive tracks on GxP-grade MLOps, validation frameworks for generative models, prompt and evaluation strategy for regulated environments, and the human capital challenge, how organisations are actually restructuring teams around AI-native ways of working.
Upcoming AI conferences

Digital Pathology and AI Congress
The advances and applications of digital pathology; artificial intelligence and machine learning for primary diagnosis and clinical research.
- Dates
- 9–10 Dec 2026
- Location
- London, UK

Teleradiology World
Connecting Radiologists, AI and Imaging Networks
- Dates
- 29–30 Apr 2027
- Location
- London, United Kingdom
Reports
View allSelf-learning AI: a boost for digital pathology
Self-learning artificial intelligence approaches are offering a number of advantages for digital pathology when compared to established AI options
Videos
View allSlide decks
View allSpatial Omics in Lung Cancer: Merging Transcriptomics and Proteomics for Deeper Insights
Slides: Kimberly Smythe, Head of Translational Pathology, Fred Hutchinson Cancer Center
Clinical Biomarkers and Therapy Candidates via Spatial Analysis
Slides: Alexander Xu, Assistant Professor of Bioengineering, University of Maryland
Reimagining Pathology: A Seamless Transformation from Slides to Generative Insight
Slides: Osamu Iizuka, CEO, Medmain Inc.
Making the Business Case for Digital Pathology in Pharma and Consultancy
An Interview with Dr. Elizabeth Neyens
Related topics
FAQs
AI at Global Engage, questions we hear most
Get the briefing
Stay ahead in AI
Monthly updates on upcoming conferences, new research and industry moves in this space.